SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K
                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

        Date of Report (Date of earliest event reported): April 22, 2004

                            DRAGON PHARMACEUTICAL INC
               (Exact Name of Registrant as Specified in Charter)


            Florida                       0-27937               65-0142474
(State or Other Jurisdiction of    (Commission File Number)    (IRS Employer
        Incorporation)                                       Identification No.)


        1055 Hastings Street, Suite 1900              V6E 2E9
          Vancouver, British Columbia                (Zip Code)
    (Address of Principal Executive Offices)




       Registrant's telephone number, including area code: (604) 669-8817

                                       N/A
          (Former Name or Former Address, if Changed Since Last Report)


<PAGE>


Item 7. Financial Statements and Exhibits

     (c) Exhibits

          99.1 Press release dated April 22, 2004

Item 12. Results of Operations and Financial Condition

     The purpose of this current  report on Form 8-K is to disclose  that Dragon
Pharmaceutical  Inc.  issued a press  release on April 22, 2004  announcing  and
summarizing its financial  results for the three and twelve-month  period ending
December 31, 2003.


                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                            DRAGON PHARMACEUTICAL INC.

Date: April 29, 2004                  By:   /s/  Matthew Kavanagh
                                            ------------------------------------
                                      Name:         Matthew Kavanagh
                                      Title:  Director of Finance and Compliance
                                             (Principal Financial and Accounting
                                                         Officer)
[{"type": "8-K", "sequence": "1", "filename": "form8k04292004.txt", "description": "FORM 8K RE YE DEC 31 2003", "secsgml_size_bytes": 2303}]
{"company-data": {"conformed-name": "DRAGON PHARMACEUTICALS INC", "cik": "0001075206", "assigned-sic": "2834", "irs-number": "650142474", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-27937", "film-number": "04765091"}, "business-address": {"street1": "543 GRANVILLE STREET SUITE 1200", "city": "VANCOUVER BC V6C 1X8", "state": "A1"}, "mail-address": {"street1": "543 GRANVILLE STREET SUITE 1200", "street2": "VANCOUVER BRITISH COLUMBIA CANADA V6C1X", "city": "VANCOUVER BRITISH CO"}}
SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K
                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

        Date of Report (Date of earliest event reported): April 22, 2004

                            DRAGON PHARMACEUTICAL INC
               (Exact Name of Registrant as Specified in Charter)

            Florida                       0-27937               65-0142474
(State or Other Jurisdiction of    (Commission File Number)    (IRS Employer
        Incorporation)                                       Identification No.)

        1055 Hastings Street, Suite 1900              V6E 2E9
          Vancouver, British Columbia                (Zip Code)
    (Address of Principal Executive Offices)

       Registrant's telephone number, including area code: (604) 669-8817

                                       N/A
          (Former Name or Former Address, if Changed Since Last Report)
Item 7. Financial Statements and Exhibits

     (c) Exhibits

          99.1 Press release dated April 22, 2004

Item 12. Results of Operations and Financial Condition

     The purpose of this current  report on Form 8-K is to disclose  that Dragon
Pharmaceutical  Inc.  issued a press  release on April 22, 2004  announcing  and
summarizing its financial  results for the three and twelve-month  period ending
December 31, 2003.

                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                            DRAGON PHARMACEUTICAL INC.

Date: April 29, 2004                  By:   /s/  Matthew Kavanagh
                                            ------------------------------------
                                      Name:         Matthew Kavanagh
                                      Title:  Director of Finance and Compliance
                                             (Principal Financial and Accounting
                                                         Officer)